RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer

Harnessing RNA interference (RNAi) to silence aberrant gene expression is an emerging approach in cancer therapy. Selective inhibition of an overexpressed gene via RNAi requires a highly efficacious, target-specific short interfering RNA (siRNA) and a safe and efficient delivery system. We have deve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Seth, Shaguna, Matsui, Yoshiyuki, Fosnaugh, Kathy, Liu, Yan, Vaish, Narendra, Adami, Roger, Harvie, Pierrot, Johns, Rachel, Severson, Gregory, Brown, Tod, Takagi, Akihide, Bell, Susan, Chen, Yan, Chen, Feng, Zhu, Tianying, Fam, Renata, Maciagiewicz, Iwona, Kwang, Erin, McCutcheon, Michael, Farber, Ken, Charmley, Patrick, Houston Jr., Michael E, So, Alan, Templin, Michael V, Polisky, Barry
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098637/
https://ncbi.nlm.nih.gov/pubmed/21364537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.21
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars